Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MRNA · against 1,335 other Healthcare companies
Ranked #1,143 of 1,336 · scores higher than 14% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 10–19, including MRNA · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | MRNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -46.6% | 4.7% | 13% | 33% | |
| Operating marginHigher is better · 1,251 reported | -149.0% | 7.1% | 11% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -28.7% | 1.7% | 15% | 33% | |
| Return on equityHigher is better · 1,252 reported | -39.0% | 3.2% | 19% | Context only | |
| Gross marginHigher is better · 1,394 reported | -66.0% | 45.9% | 2% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,143 | 23.5B USD | 14 | 27 | |
| 1,143 | 390.5B IDR (≈$24M) | 14 | 8 | |
| 1,143 | 22.8B USD | 14 | 38 | |
| 1,143 | 1.7B USD | 14 | 46 | |
| 1,143 | 91.2B USD | 14 | 18 | |
| 1,143 | 170M USD | 14 | 35 | |
| 1,143 | 41.6B USD | 14 | 34 | |
| 1,143 | 2.0B USD | 14 | 26 | |
| 1,143 | 684M USD | 14 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score